Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C9H9NO3.C4H11NO |
| Molecular Weight | 268.3089 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCO.CC(=O)NC1=CC=C(C=C1)C(O)=O
InChI
InChIKey=XTWZHJXJIIUEJP-UHFFFAOYSA-N
InChI=1S/C9H9NO3.C4H11NO/c1-6(11)10-8-4-2-7(3-5-8)9(12)13;1-5(2)3-4-6/h2-5H,1H3,(H,10,11)(H,12,13);6H,3-4H2,1-2H3
| Molecular Formula | C4H11NO |
| Molecular Weight | 89.1362 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C9H9NO3 |
| Molecular Weight | 179.1727 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DEANOL is an inactive component of CERAVE® hydrocortisone anti-itch cream, which is used for temporarily relieve itching associated with minor skin irritations, inflammation, and rashes due to eczema, soaps, detergents, cosmetics, seborrheic dermatitis, psoriasis. DEANOL is also used as a food additive.
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
0.1 % single, topical Highest studied dose Dose: 0.1 % Route: topical Route: single Dose: 0.1 % Sources: Page: p.10 |
healthy Health Status: healthy Sources: Page: p.10 |
|
6000 mg 1 times / day multiple, oral Highest studied dose Dose: 6000 mg, 1 times / day Route: oral Route: multiple Dose: 6000 mg, 1 times / day Sources: Page: p.188 |
unhealthy Health Status: unhealthy Condition: Involuntary movement disorders Sources: Page: p.188 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Inhibitors of choline uptake and metabolism cause developmental abnormalities in neurulating mouse embryos. | 2001 Aug |
|
| The relationship between the interfacial properties of surfactants and their toxicity to aquatic organisms. | 2001 Mar 1 |
|
| Improved method for the quality assurance of [C-11]choline. | 2002 Apr |
|
| Perturbations in choline metabolism cause neural tube defects in mouse embryos in vitro. | 2002 Apr |
|
| Preparation of phytate-removed deamidated soybean globulins by ion exchangers and characterization of their calcium-binding ability. | 2002 Jan 2 |
|
| Studies of the side chain cleavage of deramciclane in rats with radiolabelled compounds. | 2002 Mar |
|
| [18F]fluoromethyl triflate, a novel and reactive [18F]fluoromethylating agent: preparation and application to the on-column preparation of [18F]fluorocholine. | 2002 Sep |
|
| Water-soluble biodegradable cationic polyphosphazenes for gene delivery. | 2003 May 20 |
|
| Phosphazene-based ionic liquids: synthesis, temperature-dependent viscosity, and effect as additives in water lubrication of silicon nitride ceramics. | 2004 Aug 23 |
|
| [11C]Choline as a PET biomarker for assessment of prostate cancer tumor models. | 2004 Jun 1 |
|
| Copper (II)-mediated arylation with aryl boronic acids for the N-derivatization of pyrazole libraries. | 2004 May-Jun |
|
| The role of dimethylaminoethanol in cosmetic dermatology. | 2005 |
|
| Synthesis of isostructural cage complexes of copper with cobalt and nickel for deposition of mixed ceramic oxide materials. | 2006 Dec 25 |
|
| The evolution of senescence and post-reproductive lifespan in guppies (Poecilia reticulata). | 2006 Jan |
|
| Synthesis and characterization of succinylcholine-d18 and succinylmonocholine-d3 designed for simultaneous use as internal standards in mass spectrometric analyses. | 2007 Jul |
|
| Improved automated synthesis of [18F]fluoroethylcholine as a radiotracer for cancer imaging. | 2007 May 1 |
|
| Randomised, placebo-controlled, double-blind, split-face study on the clinical efficacy of Tricutan on skin firmness. | 2007 Nov |
|
| Synthesis, cytotoxicity, DNA interaction, and topoisomerase II inhibition properties of novel indeno[2,1-c]quinolin-7-one and indeno[1,2-c]isoquinolin-5,11-dione derivatives. | 2008 Jun 26 |
|
| Strong intramolecular Si-N interactions in the chlorosilanes Cl3-nHnSiOCH2CH2NMe2 (n = 1-3). | 2008 Nov 17 |
|
| Quantitative determination of dimethylaminoethanol in cosmetic formulations by nuclear magnetic resonance spectroscopy. | 2008 Nov-Dec |
|
| In vivo skin effects of a dimethylaminoethanol (DMAE) based formulation. | 2009 Dec |
|
| Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studies. | 2009 Dec |
|
| Mitochondrial 2,4-dienoyl-CoA reductase deficiency in mice results in severe hypoglycemia with stress intolerance and unimpaired ketogenesis. | 2009 Jul |
|
| The pentameric vertex proteins are necessary for the icosahedral carboxysome shell to function as a CO2 leakage barrier. | 2009 Oct 21 |
|
| Application of high performance liquid chromatography coupled to on-line solid-phase extraction-nuclear magnetic resonance spectroscopy for the analysis of degradation products of V-class nerve agents and nitrogen mustard. | 2010 Apr 23 |
|
| First efficient synthesis of fluorinated glycidic esters from ketones. | 2010 Feb 19 |
|
| Mesotherapy - The french connection. | 2010 Jan |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:03:49 UTC 2023
by
admin
on
Fri Dec 15 15:03:49 UTC 2023
|
| Record UNII |
JSQ17GL1CN
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C47795
Created by
admin on Fri Dec 15 15:03:49 UTC 2023 , Edited by admin on Fri Dec 15 15:03:49 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
97399
Created by
admin on Fri Dec 15 15:03:49 UTC 2023 , Edited by admin on Fri Dec 15 15:03:49 UTC 2023
|
PRIMARY | |||
|
3635-74-3
Created by
admin on Fri Dec 15 15:03:49 UTC 2023 , Edited by admin on Fri Dec 15 15:03:49 UTC 2023
|
PRIMARY | |||
|
DTXSID60189880
Created by
admin on Fri Dec 15 15:03:49 UTC 2023 , Edited by admin on Fri Dec 15 15:03:49 UTC 2023
|
PRIMARY | |||
|
22361
Created by
admin on Fri Dec 15 15:03:49 UTC 2023 , Edited by admin on Fri Dec 15 15:03:49 UTC 2023
|
PRIMARY | RxNorm | ||
|
222-858-7
Created by
admin on Fri Dec 15 15:03:49 UTC 2023 , Edited by admin on Fri Dec 15 15:03:49 UTC 2023
|
PRIMARY | |||
|
C004777
Created by
admin on Fri Dec 15 15:03:49 UTC 2023 , Edited by admin on Fri Dec 15 15:03:49 UTC 2023
|
PRIMARY | |||
|
C76621
Created by
admin on Fri Dec 15 15:03:49 UTC 2023 , Edited by admin on Fri Dec 15 15:03:49 UTC 2023
|
PRIMARY | |||
|
JSQ17GL1CN
Created by
admin on Fri Dec 15 15:03:49 UTC 2023 , Edited by admin on Fri Dec 15 15:03:49 UTC 2023
|
PRIMARY | |||
|
SUB01558MIG
Created by
admin on Fri Dec 15 15:03:49 UTC 2023 , Edited by admin on Fri Dec 15 15:03:49 UTC 2023
|
PRIMARY | |||
|
19265
Created by
admin on Fri Dec 15 15:03:49 UTC 2023 , Edited by admin on Fri Dec 15 15:03:49 UTC 2023
|
PRIMARY | |||
|
100000084678
Created by
admin on Fri Dec 15 15:03:49 UTC 2023 , Edited by admin on Fri Dec 15 15:03:49 UTC 2023
|
PRIMARY | |||
|
m4115
Created by
admin on Fri Dec 15 15:03:49 UTC 2023 , Edited by admin on Fri Dec 15 15:03:49 UTC 2023
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |